These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35523409)
1. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia. Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409 [TBL] [Abstract][Full Text] [Related]
2. Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants. Euteneuer JC; Kerns E; Leiting C; McCulloh RJ; Peeples ES J Perinatol; 2021 Jan; 41(1):53-61. PubMed ID: 32759956 [TBL] [Abstract][Full Text] [Related]
3. Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants. Slaughter JL; Klebanoff MA; Hade EM Paediatr Perinat Epidemiol; 2024 Aug; 38(6):495-504. PubMed ID: 38192005 [TBL] [Abstract][Full Text] [Related]
4. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
5. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA; JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344 [TBL] [Abstract][Full Text] [Related]
6. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia. Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR J Perinatol; 2015 Jan; 35(1):61-6. PubMed ID: 25102319 [TBL] [Abstract][Full Text] [Related]
7. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. Shah SS; Ohlsson A; Halliday HL; Shah VS Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034 [TBL] [Abstract][Full Text] [Related]
8. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia. Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252 [TBL] [Abstract][Full Text] [Related]
9. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia. Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155 [TBL] [Abstract][Full Text] [Related]
10. Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis. Shinwell ES; Portnov I; Meerpohl JJ; Karen T; Bassler D Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940717 [TBL] [Abstract][Full Text] [Related]
11. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis. Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823 [TBL] [Abstract][Full Text] [Related]
12. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906 [TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions. Clouse BJ; Jadcherla SR; Slaughter JL PLoS One; 2016; 11(2):e0148188. PubMed ID: 26840339 [TBL] [Abstract][Full Text] [Related]
14. Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia. House M; Nathan A; Bhuiyan MAN; Ahlfeld SK Pediatr Pulmonol; 2021 Aug; 56(8):2589-2596. PubMed ID: 34002957 [TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis]. Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229 [No Abstract] [Full Text] [Related]
16. Exploring the Association of Male Sex With Adverse Outcomes in Severe Bronchopulmonary Dysplasia: A Retrospective, Multicenter Cohort Study. Hammond JD; Kielt MJ; Conroy S; Lingappan K; Austin ED; Eldredge LC; Truog WE; Abman SH; Nelin LD; Guaman MC Chest; 2024 Mar; 165(3):610-620. PubMed ID: 37879559 [TBL] [Abstract][Full Text] [Related]
17. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia. Upadhyay K; Vallarino DA; Talati AJ BMC Pediatr; 2020 Sep; 20(1):414. PubMed ID: 32873254 [TBL] [Abstract][Full Text] [Related]
19. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants. Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701 [TBL] [Abstract][Full Text] [Related]
20. Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. Greenberg RG; Gayam S; Savage D; Tong A; Gorham D; Sholomon A; Clark RH; Benjamin DK; Laughon M; Smith PB; J Pediatr; 2019 May; 208():134-140.e2. PubMed ID: 30579586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]